Back to top
more

Myriad Genetics: (MYGN)

(Market Close from NSDQ)

 Add to portfolio

Save at Trade

$37.47 USD

37.47
795,044

+1.04 (3.07%)

Updated Aug 31, 2015 03:57 PM ET

Volume: 795,044

Open: $36.33

Prior Close: $36.43

Zacks Rank : 3-Hold [?]     3    

Style Scores [?] : Growth: B | Value: B | Momentum: D

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Zacks Style Score A
Growth Score A
Value Score A
Momentum Score A
Income Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The three scores are based on the trading styles of Growth, Value, and Momentum.

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

After-Market: $37.59 +0.12 (0.32%) 7:58 PM ET

Income Statements

The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.

We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:

Growth Score A
Value Score A
Momentum Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.

Zacks Scorecard Education - Learn more about the Zacks Scorecard

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/15 6/30/14 6/30/13 6/30/12 6/30/11
Sales 723 778 613 496 402
Cost Of Goods 147 109 80 65 47
Gross Profit 576 669 534 431 355
Selling & Adminstrative & Depr. & Amort Expenses 442 395 306 251 198
Income After Depreciation & Amortization 134 274 228 180 158
Non-Operating Income 1 3 5 4 2
Interest Expense 0 0 0 0 0
Pretax Income 135 278 233 185 160
Income Taxes 55 102 86 72 59
Minority Interest 0 0 0 0 0
Investment Gains/Losses 0 0 0 0 0
Other Income/Charges 0 0 0 0 0
Income From Cont. Operations 80 176 147 112 101
Extras & Discontinued Operations 0 0 0 0 0
Net Income 80 176 147 112 101
Depreciation Footnote 6/30/15 6/30/14 6/30/13 6/30/12 6/30/11
Income Before Depreciation & Amortization 159 288 237 189 165
Depreciation & Amortization (Cash Flow) 25 14 9 9 7
Income After Depreciation & Amortization 134 274 228 180 158
Earnings Per Share Data 6/30/15 6/30/14 6/30/13 6/30/12 6/30/11
Average Shares 74.50 78.18 83.33 86.47 91.70
Diluted EPS Before Non-Recurring Items 1.45 2.43 1.77 1.30 1.10
Diluted Net EPS 1.08 2.25 1.77 1.30 1.10

Fiscal Year end for MYRIAD GENETICS falls in the month of June .

All items in Millions except EPS data.

6/30/15 3/31/15 12/31/14 9/30/14 6/30/14
Sales 189.89 179.99 184.39 168.84 188.77
Cost Of Goods 38.39 36.29 37.85 34.87 30.98
Gross Profit 151.50 143.69 146.54 133.97 157.79
SG&A, R&D, and Dept/Amort Expenses 115.30 107.95 110.20 108.05 104.54
Income After SG&A, R&D, and Dept/Amort Expenses 36.20 35.74 36.34 25.92 53.25
Non-Operating Income -0.68 -0.17 1.60 -0.04 -0.70
Interest Expense 0.00 0.00 0.00 0.00 0.00
Pretax Income 35.52 35.57 37.94 25.88 52.55
Income Taxes 16.81 14.09 13.91 9.90 18.92
Minority Interest 0.00 0.00 0.00 0.00 0.00
Investment Gains/Losses 0.00 0.00 0.00 0.00 0.00
Other Income/Charges 0.00 0.00 0.00 0.00 0.00
Income From Cont. Operations 18.71 21.48 24.03 15.98 33.63
Extras & Discontinued Operations 0.00 -0.13 0.00 0.00 0.00
Net Income 18.71 21.48 24.03 15.98 33.63
Earnings Per Share Data 6/30/15 3/31/15 12/31/14 9/30/14 6/30/14
Average Shares 72.40 73.87 75.40 76.09 77.68
Diluted EPS Before Non-Recurring Items 0.41 0.40 0.40 0.25 0.48
Diluted Net EPS 0.26 0.29 0.32 0.21 0.43
 

MYGN Chart by YCharts